about
Proteomics-based discovery of biomarkers for paediatric acute lymphoblastic leukaemia: challenges and opportunitiesRedefining ALL classification: toward detecting high-risk ALL and implementing precision medicine12q24 locus association with type 1 diabetes: SH2B3 or ATXN2?LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitorsCo-existence of IL7R high and SH2B3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunctionAge-related mutations associated with clonal hematopoietic expansion and malignanciesLNK (SH2B3): paradoxical effects in ovarian cancer.Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study.Genomic Profile of Chronic Lymphocytic Leukemia in Korea Identified by Targeted Sequencing.The genomic landscape of juvenile myelomonocytic leukemia.Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal CancerA meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration.Total and Differential Leukocyte Counts in Relation to Incidence of Diabetes Mellitus: A Prospective Population-Based Cohort StudyEzh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic LeukemiaGenome-wide association study of colorectal cancer identifies six new susceptibility loci.SH2B3: a new leukemia predisposition gene.Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations.Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.Mechanisms of pre-B-cell receptor checkpoint control and its oncogenic subversion in acute lymphoblastic leukemia.Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia.Genomics in acute lymphoblastic leukaemia: insights and treatment implications.The function of SH2B3 (LNK) in the kidney.Myelodysplastic syndromes and acute leukemia with genetic predispositions: a new challenge for hematologists.The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.Association of established hypothyroidism-associated genetic variants with Hashimoto's thyroiditis.The potential role of PHF6 as an oncogene: a genotranscriptomic/proteomic meta-analysis.Cooperation of ETV6/RUNX1 and BCL2 enhances immunoglobulin production and accelerates glomerulonephritis in transgenic mice.Genetic susceptibility in childhood acute lymphoblastic leukemia.TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children.Clinical significance of SH2B3 (LNK) expression in paediatric B-cell precursor acute lymphoblastic leukaemia.Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.
P2860
Q26861489-FED45C69-580B-4E8E-A4E4-D31016DB7DA2Q26864460-5E3ACFD1-96F1-478C-8394-921E22F092F8Q28242134-F58905EF-650B-4005-B9F3-39DF4B88EAD1Q28274115-94C19A0E-E6D2-485B-80C5-7B72A644C08FQ28276513-4FBD3CF5-5272-4AA3-88C7-1C497CB5613BQ28387160-B688AFA7-6E80-4404-904D-A012131DCB46Q34302585-FE1C0DD6-5170-4F07-BF45-29C0094D81F3Q34500075-D9437DF0-03B4-466A-9283-893F80F701E2Q36222022-C0D30F93-F66F-4349-AB2D-29B6D653F6D6Q36225715-62644C6D-EBE6-4E99-AD74-484171F5830DQ36232164-218D320D-49E8-4F4F-8BA9-6075D7531B10Q36265886-91826D3B-F87E-43C1-BF02-746E42DD2A32Q36468916-0688C3F1-D04D-4687-8AE4-D5F4A6F272B9Q36593267-825573E3-4EB6-4335-897E-04C0CE352B74Q36682938-185796BF-3C58-4E52-8A8F-DFA442FDE99FQ37140021-23C65449-5F86-420F-A6BA-412B7DBB9ED7Q37215106-5F6D2919-80DD-4841-A1D2-8063A9B01F8AQ37257158-9E402102-B0B3-4634-A20B-6A66C261B22CQ37665574-B3EAD997-FD81-4DDB-ACC7-D97A97BE55D5Q38289046-3860A622-F600-4DB3-9268-F0B4443AE924Q38289596-90E351F3-7561-4C13-8849-2561C5368852Q38381463-898FFE82-C32D-45E5-906D-7EFD876CE402Q38903897-9B830776-7A60-401C-B92D-1DC1B9669984Q39000607-BD585F01-7A45-4F0C-8722-393E70154552Q39292396-7E0CEE64-D289-493C-9187-2D7ADA17E85CQ40255750-D16E5820-CECC-4FB6-8A50-62F36C579C0EQ40329193-DB4B96A9-0BFA-4D9E-8F35-AFAAA5D1545CQ42594064-48E7A451-2FE1-4C17-BC3A-557019EAF36FQ47193441-95C320FB-CF0C-49BB-90CD-8EF828503C3CQ47564553-BD8F37C1-B425-4A50-B6E3-2CB461E19C7BQ48106616-4B20BC10-7EB1-49A8-BDA1-196E7175D63EQ49959951-5132133F-EAC5-43E3-8D3F-925347077930Q52793910-4791FFE7-07E4-44F8-8C83-9F03681613F6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic loss of SH2B3 in acute lymphoblastic leukemia.
@en
Genetic loss of SH2B3 in acute lymphoblastic leukemia.
@nl
type
label
Genetic loss of SH2B3 in acute lymphoblastic leukemia.
@en
Genetic loss of SH2B3 in acute lymphoblastic leukemia.
@nl
prefLabel
Genetic loss of SH2B3 in acute lymphoblastic leukemia.
@en
Genetic loss of SH2B3 in acute lymphoblastic leukemia.
@nl
P2093
P2860
P50
P1433
P1476
Genetic loss of SH2B3 in acute lymphoblastic leukemia.
@en
P2093
Adolfo A Ferrando
Arianne Perez-Garcia
Chaim Jalas
Charles A LeDuc
Isaura Rigo
Jacob M Rowe
Janis Racevskis
Kara Kelly
Maddalena Paganin
Michael Hadler
P2860
P304
P356
10.1182/BLOOD-2013-05-500850
P407
P577
2013-08-01T00:00:00Z